Trials / Completed
CompletedNCT02303080
Whey Protein Micelles and Thermogenesis in Overweight Subjects
Whey Protein Micelles and Thermogenesis In Overweight Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The main objective of the trial is to measure the thermogenic effect of two different doses of whey protein microgels. It will be a randomized crossover double-blind design conducted in 20 subjects.
Detailed description
Primary objective and outcome: The primary objective of the trial is to measure the thermogenic effect of two different doses of whey protein microgels (WPM). Secondary objectives and outcomes: Explore the mechanism of action of WPM on thermogenesis including: Protein turnover in response to the dose and the source of protein (WPM versus casein) Insulinemic and glycemic response to the dose and source of protein (WPM versus casein) Design: The proposed study is a randomized double-blind, placebo-controlled, single center, crossover design. At the start of the study, subjects will be randomly assigned to 4 different groups in a crossover design, where they will be asked to consume a beverage containing Product 1: 0g of protein (maltodextrin control) Product 2: 30g of WPM Product 3: 50g of WPM Product 4: 50g of micellar casein (MC) Number of subjects: The number of subjects will be 15. Sufficient subjects should be recruited to provide a 30% drop-out rate. Therefore 20 subjects will be needed including drop-outs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Control (WPM 0) | 85.0 % maltodextrin,15.0% fat, 0% WPM |
| OTHER | WPM 30 | 43.7% maltodextrin, 15.2% fat, 41.1% (30 g) WPM |
| OTHER | WPM 50 | 16.3% maltodextrin, 15.2% fat, 68.5% (50 g) WPM |
| OTHER | MC 50 | 16.7% maltodextrin, 15.0% fat, 68.2% (50 g) MC |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2012-06-01
- Completion
- 2012-12-01
- First posted
- 2014-11-27
- Last updated
- 2025-05-14
Source: ClinicalTrials.gov record NCT02303080. Inclusion in this directory is not an endorsement.